Academic literature on the topic 'Digoxin'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Digoxin.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Digoxin"
Wang, Kai-di, Xiang Ding, Nan Jiang, Chao Zeng, Jing Wu, Xian-yi Cai, Aubryanna Hettinghouse, et al. "Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis." Annals of the Rheumatic Diseases 81, no. 4 (December 1, 2021): 544–55. http://dx.doi.org/10.1136/annrheumdis-2021-221380.
Full textWermeling, Daniel P., Carinda J. Feild, Deborah A. Smith, Mary H. H. Chandler, G. Dennis Clifton, and Duane A. Boyle. "Effects of Long‐Term Oral Carvedilol on the Steady‐State Pharmacokinetics of Oral Digoxin in Patients With Mild to Moderate Hypertension." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 14, no. 5 (September 10, 1994): 600–606. http://dx.doi.org/10.1002/j.1875-9114.1994.tb02857.x.
Full textScalese, Michael J., and Dominick J. Salvatore. "Role of Digoxin in Atrial Fibrillation." Journal of Pharmacy Practice 30, no. 4 (April 10, 2016): 434–40. http://dx.doi.org/10.1177/0897190016642361.
Full textQadhi, Rawabi, Tran Tran, Stefanie Lip, Ogor Team, Linsay Macallum, and Sandosh Padmanabhan. "ASSESSING THE CLINICAL IMPACT OF PROTON PUMP INHIBITOR-DIGOXIN INTERACTIONS: A RETROSPECTIVE COHORT STUDY OF HOSPITALIZATION AND MORTALITY RISK." Journal of Hypertension 42, Suppl 1 (May 2024): e253-e254. http://dx.doi.org/10.1097/01.hjh.0001022092.07013.e9.
Full textRen, Yulin, Sijin Wu, Joanna E. Burdette, Xiaolin Cheng, and A. Douglas Kinghorn. "Structural Insights into the Interactions of Digoxin and Na+/K+-ATPase and Other Targets for the Inhibition of Cancer Cell Proliferation." Molecules 26, no. 12 (June 16, 2021): 3672. http://dx.doi.org/10.3390/molecules26123672.
Full textSuryoputri, Masita Wulandari, Laksmi Maharani, and Ika Mustikaningtias. "Penyesuaian Dosis Digoxin pada Pasien Gagal Jantung di RSUD Margono Soekardjo Purwokerto." JURNAL ILMU KEFARMASIAN INDONESIA 19, no. 2 (December 28, 2021): 248. http://dx.doi.org/10.35814/jifi.v19i2.778.
Full textCremer, Edivaldo, Almir Conrrado Rodrigues de Lima, Larissa Laila Cassarotti, Gabrielle Rodrigues Munhoz, Romulo Jordão Barbosa Pedrinho, and Roberto Kenji Nakamura Cuman. "Mortalidade de indivíduos idosos cardíacos tratados com digoxina." Revista Recien - Revista Científica de Enfermagem 10, no. 29 (March 31, 2020): 120–28. http://dx.doi.org/10.24276/rrecien2358-3088.2020.10.29.120-128.
Full textAllen, Nancy M., Gary D. Dunham, Jeffrey M. Sailstad, and John W. A. Findlay. "Clinical and Pharmacokinetic Profiles of Digoxin Immune Fab in Four Patients with Renal Impairment." DICP 25, no. 12 (December 1991): 1315–20. http://dx.doi.org/10.1177/106002809102501205.
Full textMoffett, Brady S., April Garner, Troy Zapata, Jeffrey Orcutt, Mary Niu, and Keila N. Lopez. "Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population." Cardiology in the Young 26, no. 3 (April 27, 2015): 493–98. http://dx.doi.org/10.1017/s1047951115000505.
Full textDasgupta, Amitava, Laura Kidd, Brian J. Poindexter, and Roger J. Bick. "Interference of Hawthorn on Serum Digoxin Measurements by Immunoassays and Pharmacodynamic Interaction With Digoxin." Archives of Pathology & Laboratory Medicine 134, no. 8 (August 1, 2010): 1188–92. http://dx.doi.org/10.5858/2009-0404-oa.1.
Full textDissertations / Theses on the topic "Digoxin"
Alexandrovich, Susan K. "Characterization of monoclonal antibodies against digoxin /." Online version of thesis, 1987. http://hdl.handle.net/1850/10681.
Full textMatthewson, Beryl Ellen. "Digoxin-like immunoreactive substances in the neonate." Thesis, University of British Columbia, 1988. http://hdl.handle.net/2429/28022.
Full textMedicine, Faculty of
Pathology and Laboratory Medicine, Department of
Graduate
Hui, James. "Analysis for digoxin and metabolites in serum and digoxin disposition in the elderly with gastrointestinal disease after two oral dosage forms /." The Ohio State University, 1988. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487587604130428.
Full textHallberg, Pär. "Pharmacogenomics of antihypertensive treatment & clinical pharmacological studies of digoxin treatment /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5782.
Full textCavet, Megan Elizabeth. "Intestinal secretion of organic solutes." Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.318538.
Full textSvensson, Åsa. "Applications of a new logic to old drugs: angiogenesis inhibition in neuroblastoma /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3458.
Full textBARROS, Isabel Cristina Medeiros. "Monitoração terapêutica das concentrações plásmaticas da digoxina em pacientes com insuficiência cardíaca." Universidade Federal de Goiás, 2008. http://repositorio.bc.ufg.br/tede/handle/tde/1703.
Full textIt was investigated the clinical, lab and plasma digoxin concentration profiles in 15 cardiac heart failure (CHF) outpatients of the Cardiac Heart Service of the Goias Federal University Clinical Hospital. It was aimed to know plasma digoxin concentration profile in 15 cardiac heart failure (CHF) outpatients by two analytical methods, taking account clinical, laboratorial, habits, anthropometric data and drug usage. Digoxin dosage was developed by LC/MS/MS and immunoassay methods; questionnaire and consults handbooks were performed. Results and Conclusions: 87% of the patients who over 46 years of age (33% above 61), the masculine majority; the IC of Chagas disease origin presented greater occurrence, followed of the hipertensive and idiopatic (59%); IC functional classroom II (53.33%); hypertension and diabetes had been distinguished as co-morbidities (26.67% and 20%); tobaccoism, overweight and obesity degree I had presented low occurrence. No patients presented relevant clinical data suggestive of digitalis intoxication. No observed changes in biochemical and hematological exams. The ejection fractions were good by means 41.7 ± 9%. Some drugs with interaction potential had been associated to the treatment, apparently without alterations. Statistical significative difference between both methods was observed (P < 0.05, ANOVA, Tukey Test). In the immunoassay method, all the patients were inside of the therapeutical range (0, 5-2, 0 ng/mL), whereas for the LC-MS/MS method, 8 patients they would be in subtherapeutical concentrations. However, no patient presented signals or symptoms of poisoning or inefficacy of the digoxin, demonstrating biological variability. The two methods are useful, since that it has a correlation with the clinical and laboratorial state of the patients.
Investigou-se o perfil clínico, laboratorial e as concentrações de digoxina plasmática em 15 pacientes com insuficiência cardíaca (IC) atendidos no Ambulatório de Insuficiência Cardíaca do HC-UFG. Objetivou-se estudar o perfil de concentrações plasmáticas de digoxina em pacientes com IC, utilizando dois métodos analíticos, e descrever a digoxinemia considerando os dados clínicos, laboratoriais, hábitos, IMC e consumo de medicamentos. A metodologia utilizada consistiu de cromatografia líquida de alta eficiência acoplada a espectrometria de massas (LC/MS/MS) e Imunoensaio, aplicação de questionário e consulta a prontuários. Como resultados, observou-se: 87% dos pacientes maiores que 46 anos de idade (33% acima de 61), a maioria masculina, a IC de origem chagásica apresentou maior ocorrência, seguida da hipertensiva e idiopática (59%); IC classe funcional II (53,33%); hipertensão e diabetes destacaram-se como co-morbidades (26,67% e 20%); tabagismo, sobrepeso e obesidade grau I apresentaram baixa ocorrência. Nenhum dos pacientes apresentou dados clínicos relevantes sugestivos de intoxicação digitálica. Não houve alterações em exames bioquímicos e hematológicos. A fração de ejeção média foi 41,7 ± 9%, portanto nenhum paciente apresentou FE como preditor de mau prognóstico. Vários fármacos com potencial de interação estiveram associados ao tratamento, aparentemente sem alterações. Houve diferença significativa (P < 0,05, ANOVA, Teste de Tukey) entre os métodos analíticos. No método de imunoensaio, todos os pacientes estavam dentro da faixa terapêutica (0,5-2,0 ng/mL), enquanto que pelo método LC-MS/MS, 8 pacientes estariam em sub-dosagens. Entretanto, nenhum paciente apresentou sinais ou sintomas de intoxicação ou de ineficácia da digoxina, demonstrando variabilidade biológica. Os dois métodos são úteis, desde que haja uma correlação com o estado clínico e laboratorial dos pacientes.
Embree, Leanne. "Development of a sensitive, quantitative high-performance liquid chromatographic assay for the measurement of digoxin in patient groups with high levels of digoxin-like immunoreactive substances." Thesis, University of British Columbia, 1989. http://hdl.handle.net/2429/29093.
Full textPharmaceutical Sciences, Faculty of
Graduate
Hallberg, Pär. "Pharmacogenomics of Antihypertensive Treatment & Clinical Pharmacological Studies of Digoxin Treatment." Doctoral thesis, Uppsala universitet, Institutionen för medicinska vetenskaper, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5782.
Full textVetticaden, Santosh John. "Evaluation of Analytical, Pharmacokinetic and Pharmacodynamic Methods for the Study of Digoxin." VCU Scholars Compass, 1985. http://scholarscompass.vcu.edu/etd/5103.
Full textBooks on the topic "Digoxin"
Buchko, Sandra. The effect of nebulized salbutamol on serum digoxin concentration. [Ottawa: Ottawa General Hospital, 1991.
Find full textuniversitet, Odense, ed. Digoxin interactions: The influence of quinidine and verapamil on the pharmacokinetics and receptor binding of digitalis glycosides. Stockholm: distributed by the Almqvist & Wiksell Periodical Company, 1985.
Find full textKlüppel, Arnulf. Untersuchungen zur dosisunabhängigen Pharmakokinetik von Digoxin. [s.l.]: [s.n.], 1986.
Find full textBissland, Ted. Death shift: The digoxin murders at "Sick Kids". Toronto: Bantam, 1985.
Find full textKurup, Ravikumar, and Parameswaran Achutha Kurup. The third element: Actinidic archaea, digoxin, and the biological universe. Hauppauge, N.Y: Nova Science Publishers, 2011.
Find full textKurup, Ravikumar. Hypothalamic digoxin, cerebral dominance and brain function in health and diseases. New York: Nova Science Publishers, Inc., 2003.
Find full textJoreteg, Torbjörn. Digoxin binding to skeletal muscle: Factors of importance for an activity dependency. [s.l.]: [s.n.], 1985.
Find full textStenzel, Joachim. Der Einfluss von Nisoldipin auf die Digoxin- und Digitoxinplasmaspiegel und hämodynamische Effekte. [s.l.]: [s.n.], 1987.
Find full textDüsseldorf, Universität, ed. Der Einfluss von Digoxin auf die Kernreihenbildung in den Herzmuskelzellen des Schweines. [s.l.]: [s.n.], 1987.
Find full textPeter, Inge. Dosis-Wirkungsbeziehungen extrakardialer Effekte von Digoxin und Meproscillarin an gesunden Versuchspersonen: (placebokontrollierte Doppelblindstudie). [s.l.]: [s.n.], 1985.
Find full textBook chapters on the topic "Digoxin"
Gebran, Nicole. "Digoxin." In Textbook of Clinical Pediatrics, 2605–8. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_275.
Full textBeyer, Karl-Heinz. "Digoxin." In Biotransformation der Arzneimittel, 202–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74386-3_107.
Full textVidal, C., and W. R. Külpmann. "Digoxin." In Springer Reference Medizin, 702–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_892.
Full textVidal, C., and W. R. Külpmann. "Digoxin." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_892-1.
Full textDasgupta, Amitava. "Digoxin." In Handbook of Drug Monitoring Methods, 111–31. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-031-7_6.
Full textWilson, John Fawcett. "Digoxin." In The Immunoassay Kit Directory, 1515–32. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0679-5_15.
Full textPeter, Helga, and Thomas Penzel. "Digoxin." In Springer Reference Medizin, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2020. http://dx.doi.org/10.1007/978-3-642-54672-3_451-1.
Full textChen, Ying, Lan Sun, and Guan-Hua Du. "Digoxin." In Natural Small Molecule Drugs from Plants, 49–58. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-8022-7_8.
Full textSchneider, Achim, Günther Schlunck, and Viola Sieber. "Digoxin." In Geburtshilfefibel, 257–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-97317-8_54.
Full textAhmed, Hesham M., Christopher T. Aquina, Vicente H. Gracias, J. Javier Provencio, Mariano Alberto Pennisi, Giuseppe Bello, Massimo Antonelli, et al. "Digoxin Toxicity." In Encyclopedia of Intensive Care Medicine, 722. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_1486.
Full textConference papers on the topic "Digoxin"
Karthikeyan, Ganesan. "28 Should we be using digoxin in 2018?" In 2nd Asia Pacific Advanced Heart Failure Forum (APAHFF 2018), 16th November 2018, Hong Kong. BMJ Publishing Group Ltd, British Cardiovascular Society and Asia Pacific Heart Association, 2019. http://dx.doi.org/10.1136/heartasia-2019-apahff.28.
Full textPowell, C., M. Barrett, K. Flynn, D. Meenaghan, and K. McDonald. "54 A year in the life of digoxin." In Irish Cardiac Society 74th Annual Scientific Meeting & AGM, October 12th–14th 2023, Killashee House Hotel, Kildare, Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-ics.54.
Full textGranell, C. Liñana, L. Belles Medall, O. Pascual Marmaneu, R. Ferrando Piqueres, M. Medoza Aguilera, T. Alvarez Martin, and T. Garcia Martinez. "PKP-008 Implementation of a monitoring protocol for digoxin." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.436.
Full textMartínez Simón, JJ, A. Martín Suárez, AM Gómez Pedrero, and M. Pérez Encinas. "5PSQ-023 Adequate digoxin dosage in patients with digitalis toxicity." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.456.
Full textRodríguez Esquíroz, A., C. Leralta González, M. Jiménez Meseguer, ÁL Salcedo Mingorranz, B. García Díaz, M. Sarobe Carricas, and MF Hurtado Gómez. "5PSQ-010 Digoxin adjustment: comparative analysis of three pharmacokinetic software." In 27th EAHP Congress, Lisbon, Portugal, 22-23-24 March 2023. British Medical Journal Publishing Group, 2023. http://dx.doi.org/10.1136/ejhpharm-2023-eahp.237.
Full textSchwegman, A., S. Herasevich, Y. Subat, O. Gajic, and C. Bennett. "Digoxin Use in Patients with Sepsis: A Single-Center Retrospective Cohort Study." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6500.
Full textMagro Vázquez, C., C. González Trigueros, AL Salcedo Mingoarranz, MM Noceda Urarte, M. Herrero Fernández, MT Sarobe Carricas, G. Baldominos Utrilla, and B. García Díaz. "4CPS-103 Pharmacokinetic interaction study of osimertinib and digoxin: a case report." In 27th EAHP Congress, Lisbon, Portugal, 22-23-24 March 2023. British Medical Journal Publishing Group, 2023. http://dx.doi.org/10.1136/ejhpharm-2023-eahp.119.
Full textAbbasi, A., A. Nikfarjam, and J. Mohammadnejad. "Simulation of digoxin single molecule detection through resonant frequency shift of a CNT." In 2013 First RSI/ISM International Conference on Robotics and Mechatronics (ICRoM 2013). IEEE, 2013. http://dx.doi.org/10.1109/icrom.2013.6510132.
Full textLópez-Sepúlveda, R., E. Espínola García, MS Martín Sances, S. Anaya Ordóñez, MA García Lirola, and J. Cabeza Barrera. "PKP-006 Pharmacist’s role in clinical pharmacokinetic monitoring of digoxin: minimising toxic effects." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.434.
Full textPothal, S., N. Tengli, N. Patel, and A. Behera. "Efficacy of Digoxin in isolated Right ventricular Dysfunction due to Chronic Pulmonary Diseases." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.135.
Full text